GTS Securities’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-121,600
Closed -$1.12M 3795
2024
Q3
$1.12M Sell
121,600
-35,800
-23% -$296K ﹤0.01% 2063
2024
Q2
$1.54M Buy
157,400
+2,000
+1% +$24.4K ﹤0.01% 1711
2024
Q1
$2.35M Sell
155,400
-8,600
-5% -$156K ﹤0.01% 1376
2023
Q4
$3.53M Sell
164,000
-54,100
-25% -$998K 0.01% 1239
2023
Q3
$4.05M Buy
+218,100
New +$5.09M 0.01% 1053

Other funds holding TDOC

GTS Securities's TDOC Position: Q3 2024 in Review

GTS Securities sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 32,078 shares — an estimated $265K sold.

GTS Securities first reported a position in TDOC in Q2 2023 and held it in 5 quarters. The position peaked at $2.47M in Q4 2023. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • GTS Securities reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • GTS Securities sold 32,078 Teladoc Health shares in Q3 2024, an estimated $265K.
  • GTS Securities first reported a position in Teladoc Health in Q2 2023 and held it in 5 quarters.
  • GTS Securities's Teladoc Health position peaked at $2.47M in Q4 2023.
  • 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on GTS Securities's 13F filing for Q3 2024, filed 13 Nov 2024.